ReviewCNS drugs2017

Health-Related Quality of Life in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs.

Peter Joseph JongenPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.